ST Pharm Co.Ltd Capital Reinvestment Ratio
ST Pharm Co.Ltd capital reinvestment ratio. ST Pharm Co.Ltd (237690) has a Capital Reinvestment Ratio of 0.50x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩29.25 Billion) in capital expenditures (₩14.61 Billion). See ST Pharm Co.Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ST Pharm Co.Ltd (2015–2025)
Capital reinvestment ratio of ST Pharm Co.Ltd from 2015 to 2025. This chart tracks ST Pharm Co.Ltd's Capital Reinvestment Ratio across 9 annual periods. See 237690 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
ST Pharm Co.Ltd Capital Reinvestment Ratio by Year (2015–2025)
ST Pharm Co.Ltd capital reinvestment ratio by year from 2015 to 2025. For the full cash flow conversion analysis, see ST Pharm Co.Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.38x | ₩13.99 Billion | ₩47.29 Billion | ▲ +344.5% |
| 2024 | 0.76x | ₩109.45 Billion | ₩83.22 Billion | ▼ -97.7% |
| 2023 | 33.46x | ₩1.30 Billion | ₩43.44 Billion | ▲ +287.8% |
| 2022 | 8.63x | ₩7.03 Billion | ₩60.66 Billion | ▲ +21.1% |
| 2021 | 7.12x | ₩7.27 Billion | ₩51.79 Billion | ▲ +182.4% |
| 2018 | 2.52x | ₩10.77 Billion | ₩27.17 Billion | ▲ +395.9% |
| 2017 | 0.51x | ₩54.44 Billion | ₩27.70 Billion | ▲ +61.1% |
| 2016 | 0.32x | ₩50.78 Billion | ₩16.03 Billion | ▼ -49.5% |
| 2015 | 0.63x | ₩35.82 Billion | ₩22.40 Billion | — |